The association between obesity and outcomes in acute pancreatitis: an individual patient data meta-analysis.


Journal

European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 7 11 2018
medline: 29 5 2019
entrez: 7 11 2018
Statut: ppublish

Résumé

There are data to suggest that obesity is associated with local and systemic complications as well as mortality in acute pancreatitis (AP). Cohort studies to date, however, have shown conflicting results from mostly unadjusted analyses. Therefore, we performed an individual patient data meta-analysis with the primary aim to investigate the association between obesity and mortality in AP. Our secondary aim was to investigate the association between obesity and necrosis, organ failure, multiple organ failure, and invasive intervention. We systematically searched four electronic databases for prospective studies on obesity and outcomes in AP. Researchers of eligible studies were invited to share individual patient data using a standardized data collection form. All end points were investigated with a one-stage mixed effects Poisson model with random intercepts and forced entry of relevant confounders. We included five databases with 1302 patients, of whom 418 (32%) were obese. In total, 466 (36%) patients had necrosis, 328 (25%) had organ failure, 188 (14%) had multiple organ failure, 210 (16%) had an intervention, and 84 (7%) patients died. We found no significant association between obesity and mortality [relative risk (RR) 1.40, 95% confidence interval (CI): 0.89-2.20], necrosis (RR: 1.08, 95% CI: 0.90-1.31) or invasive intervention (RR: 1.10, 95% CI: 0.83-1.47) after adjustment for confounders. However, obesity was independently associated with the development of organ failure (RR: 1.38, 95% CI: 1.11-1.73) and multiple organ failure (RR: 1.81, 95% CI: 1.35-2.42). Obesity is independently associated with the development of organ failure and multiple organ failure in AP. However, there is no association between obesity and mortality, necrosis, and an intervention.

Identifiants

pubmed: 30399003
doi: 10.1097/MEG.0000000000001300
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

316-322

Commentaires et corrections

Type : CommentIn

Auteurs

Xavier J N M Smeets (XJNM)

Departments of Gastroenterology and Hepatology.

Iris Knoester (I)

Departments of Gastroenterology and Hepatology.

Karina V Grooteman (KV)

Departments of Gastroenterology and Hepatology.

Vikesh K Singh (VK)

Division of Gastroenterology, Johns Hopkins Medical Institutions, Baltimore, Maryland.

Peter A Banks (PA)

Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts.

Georgios I Papachristou (GI)

Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

Andres Duarte-Rojo (A)

Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

Guillermo Robles-Diaz (G)

Department of Pancreas Clinic-Gastroenterology, Research Division, School of Medicine, UNAM, The National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.

Wietske Kievit (W)

Health Evidence, Radboud University Medical Center, Nijmegen.

Marc G H Besselink (MGH)

Department of Surgery, Academic Medical Center, Amsterdam.

Robert C Verdonk (RC)

Departments of Gastroenterology and Hepatology.

Hjalmar C Van Santvoort (HC)

Surgery, St. Antonius Hospital, Nieuwegein.
Department of Surgery, University Medical Center Utrecht, Cancer Center, Utrecht, The Netherlands.

Joost P H Drenth (JPH)

Departments of Gastroenterology and Hepatology.

Michael Belias (M)

Health Evidence, Radboud University Medical Center, Nijmegen.

Erwin J M Van Geenen (EJM)

Departments of Gastroenterology and Hepatology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH